Gili Hart

Also affiliated with Intel (Israel)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “235 Reducing MUC5AC or MUC5B expression using antisense oligonucleotides as a therapeutic approach for cystic fibrosis and other muco-obstructive diseases”.

235 Reducing MUC5AC or MUC5B expression using antisense oligonucleotides as a therapeutic approach for cystic fibrosis and other muco-obstructive diseases

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01165-7

N/A

0DataRank · unranked

0 citations

C. Stampfer, R. Elgrabli, T. Blinder, Merav Ordan, S.A. Jubeh +6 more

236 SPL84, an antisense oligonucleotide modulating the 3849+10 kb C-T splicing defect, efficiently penetrates and restores CFTR function when treated through the apical side of primary human bronchial epithelial cells

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01166-9

N/A

0DataRank · unranked

0 citations

Yifat S. Oren, C. Stampfer, E. Ozeri-Galai, Gili Hart, Batsheva Kerem +1 more